BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17015757)

  • 1. Development of autoimmunity in IL-14alpha-transgenic mice.
    Shen L; Zhang C; Wang T; Brooks S; Ford RJ; Lin-Lee YC; Kasianowicz A; Kumar V; Martin L; Liang P; Cowell J; Ambrus JL
    J Immunol; 2006 Oct; 177(8):5676-86. PubMed ID: 17015757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of a novel monoclonal antibody against interleukin-14alpha.
    Peng X; Zhou C; Wei D; Luo Z; Zhang C
    Hybridoma (Larchmt); 2009 Aug; 28(4):235-9. PubMed ID: 19663695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y
    Woods LT; Camden JM; Khalafalla MG; Petris MJ; Erb L; Ambrus JL; Weisman GA
    Oral Dis; 2018 Jul; 24(5):761-771. PubMed ID: 29297959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ B cells in autoimmune disease and lymphoid malignancy.
    Shirai T; Hirose S; Okada T; Nishimura H
    Clin Immunol Immunopathol; 1991 May; 59(2):173-86. PubMed ID: 1706969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.
    Batten M; Fletcher C; Ng LG; Groom J; Wheway J; Laâbi Y; Xin X; Schneider P; Tschopp J; Mackay CR; Mackay F
    J Immunol; 2004 Jan; 172(2):812-22. PubMed ID: 14707051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice.
    Tsao BP; Ohnishi K; Cheroutre H; Mitchell B; Teitell M; Mixter P; Kronenberg M; Hahn BH
    J Immunol; 1992 Jul; 149(1):350-8. PubMed ID: 1607661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
    Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
    Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.
    Jain S; Ward JM; Shin DM; Wang H; Naghashfar Z; Kovalchuk AL; Morse HC
    Am J Pathol; 2017 Sep; 187(9):2020-2033. PubMed ID: 28727987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor.
    Kontoyiannis D; Kollias G
    Eur J Immunol; 2000 Jul; 30(7):2038-47. PubMed ID: 10940893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
    Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
    Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
    Dai H; He F; Tsokos GC; Kyttaris VC
    J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.
    Altman A; Theofilopoulos AN; Weiner R; Katz DH; Dixon FJ
    J Exp Med; 1981 Sep; 154(3):791-808. PubMed ID: 6456321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.
    Reininger L; Radaszkiewicz T; Kosco M; Melchers F; Rolink AG
    J Exp Med; 1992 Nov; 176(5):1343-53. PubMed ID: 1402680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of B cells from autoimmune mice to IL-5.
    Umland SP; Go NF; Cupp JE; Howard M
    J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.